Loading...
FDA Approval And BARDA Contracts Will Boost Clinical Diagnostics
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
1Y
6.8%7D
7.6%1Y
6.8%7D
7.6%You can edit this narrative until May 12 5:59 AM. Then, changes will post as Updates.
You can edit this narrative until May 12 5:59 AM. Then, changes will post as Updates.